These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 19210387)
1. Gamma-Aminobutyric Acid Modulation of Corticotrophin-Releasing Factor-41 Secretion from the Rat Hypothalamus in vitro. Tsagarakis S; Rees LH; Besser GM; Grossman A J Neuroendocrinol; 1990 Apr; 2(2):221-4. PubMed ID: 19210387 [TBL] [Abstract][Full Text] [Related]
2. Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission. Tringali G; Aubry JM; Moscianese K; Zamori C; Vairano M; Preziosi P; Navarra P; Pozzoli G J Psychiatry Neurosci; 2004 Nov; 29(6):459-66. PubMed ID: 15644987 [TBL] [Abstract][Full Text] [Related]
3. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro. Tsagarakis S; Navarra P; Rees LH; Besser M; Grossman A; Navara P Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975 [TBL] [Abstract][Full Text] [Related]
4. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis. Bagosi Z; Csabafi K; Jászberényi M; Telegdy G Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347 [TBL] [Abstract][Full Text] [Related]
5. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy. Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647 [TBL] [Abstract][Full Text] [Related]
6. Influence of fetal alcohol exposure on the GABAergic regulation of growth hormone release in postnatal rats. Blaine K; Gasser K; Conway S Alcohol Clin Exp Res; 1999 Oct; 23(10):1681-90. PubMed ID: 10550002 [TBL] [Abstract][Full Text] [Related]
7. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. Owens MJ; Knight DL; Ritchie JC; Nemeroff CB J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212 [TBL] [Abstract][Full Text] [Related]
8. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244 [TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of bullfrog corticotropin-releasing factor (CRF): effect of homologous CRF on the release of TSH from pituitary cells in vitro. Ito Y; Okada R; Mochida H; Hayashi H; Yamamoto K; Kikuyama S Gen Comp Endocrinol; 2004 Sep; 138(3):218-27. PubMed ID: 15364204 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies. Kumari M; Cover PO; Poyser RH; Buckingham JC Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of hypothalamic neuropeptides upon luteinizing hormone secretion by cultured rat anterior pituitary cells. Leiva LA; Croxatto HB Biol Res; 1994; 27(2):113-21. PubMed ID: 8640240 [TBL] [Abstract][Full Text] [Related]
13. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study. Bagosi Z; Jászberényi M; Szabó G; Telegdy G Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090 [TBL] [Abstract][Full Text] [Related]
14. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). Rivier C; Bruhn T; Vale W J Pharmacol Exp Ther; 1984 Apr; 229(1):127-31. PubMed ID: 6323684 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro. Tsagarakis S; Rees LH; Besser GM; Grossman A Brain Res; 1989 Nov; 502(1):167-70. PubMed ID: 2819453 [TBL] [Abstract][Full Text] [Related]
16. gamma-Aminobutyric acid (GABA) stimulates somatostatin release following activation of a GABA uptake carrier located on somatostatin nerve endings of rat cerebral cortex. Raiteri M; Bonanno G; Fedele E; Fontana G; Gemignani A J Pharmacol Exp Ther; 1991 Jan; 256(1):88-93. PubMed ID: 1671101 [TBL] [Abstract][Full Text] [Related]
17. The effects of rat corticotrophin-releasing factor-41 Peptide fragments on bioassay and immunoassay determination of corticotrophin-releasing factor-41 levels. Milton NG; Nicholson SA; Self CH; Hillhouse EW J Neuroendocrinol; 1990 Dec; 2(6):897-901. PubMed ID: 19215435 [TBL] [Abstract][Full Text] [Related]
18. Hypothalamic oxytocin attenuates CRF expression via GABA(A) receptors in rats. Bülbül M; Babygirija R; Cerjak D; Yoshimoto S; Ludwig K; Takahashi T Brain Res; 2011 Apr; 1387():39-45. PubMed ID: 21382355 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of GABA release from the rat neostriatum and globus pallidus in vivo by corticotropin-releasing factor. Sirinathsinghji DJ; Heavens RP Neurosci Lett; 1989 May; 100(1-3):203-9. PubMed ID: 2788252 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a short feedback of prolactin on the tubero-infundibular endings: differential effect on the release of [ h]gamma-aminobutyric Acid and [ h]dopamine from superfused median eminence. Felman K; Tappaz M J Neuroendocrinol; 1990 Jun; 2(3):375-80. PubMed ID: 19215363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]